Brown Advisory Inc Halozyme Therapeutics, Inc. Transaction History

Brown Advisory Inc

$77.3 Billion
Q3 2024

A detailed history of Brown Advisory Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 20,863 shares of HALO stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,863

Previous 20,844 0.09%

Holding current value

$1.17 Million

Previous $1.09 Million 9.35%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$51.3 - $64.42 $974 - $1,223	19 Added 0.09%	20,863 $1.19 Million
Q1 2024 Apr 24, 2024	SELL	$33.68 - $41.95 $3,906 - $4,866	-116 Reduced 0.55%	20,844 $847,000
Q4 2023 Feb 08, 2024	BUY	$33.32 - $42.1 $4,964 - $6,272	149 Added 0.72%	20,960 $774,000
Q1 2023 May 08, 2023	SELL	$32.86 - $55.7 $676,981 - $1.15 Million	-20,602 Reduced 49.75%	20,811 $794,000
Q1 2022 May 09, 2022	SELL	$31.97 - $41.06 $3,868 - $4,968	-121 Reduced 0.29%	41,413 $1.65 Million
Q4 2021 Jan 27, 2022	BUY	$31.82 - $40.75 $3,245 - $4,156	102 Added 0.25%	41,534 $1.67 Million
Q3 2021 Nov 12, 2021	BUY	$38.47 - $46.42 $730 - $881	19 Added 0.05%	41,432 $1.69 Million
Q2 2021 Jul 29, 2021	SELL	$38.84 - $51.31 $815,251 - $1.08 Million	-20,990 Reduced 33.64%	41,413 $1.88 Million
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $1,461 - $1,903	-37 Reduced 0.06%	62,403 $2.6 Million
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $2,787 - $4,710	108 Added 0.17%	62,440 $2.67 Million
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $677,013 - $779,328	26,302 Added 73.0%	62,332 $1.64 Million
Q2 2019 Aug 12, 2019	SELL	$14.75 - $17.26 $1.1 Million - $1.29 Million	-74,500 Reduced 67.4%	36,030 $619,000
Q1 2018 Jun 28, 2018	BUY	$17.06 - $21.2 $1.7 Million - $2.11 Million	99,500 Added 902.09%	110,530 $2.17 Million
Q1 2018 May 14, 2018	SELL	$17.06 - $21.2 $2.4 Million - $2.98 Million	-140,417 Reduced 92.72%	11,030 $216,000
Q4 2017 Feb 12, 2018	SELL	$16.75 - $20.8 $637,990 - $792,251	-38,089 Reduced 20.1%	151,447 $3.07 Million
Q3 2017 Nov 13, 2017	SELL	$11.76 - $17.4 $128,266 - $189,781	-10,907 Reduced 5.44%	189,536 $3.29 Million
Q2 2017 Aug 14, 2017	BUY	N/A	200,443	200,443 $2.57 Million

Others Institutions Holding HALO

# of Institutions

540

Shares Held

126M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.8B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Account

Brown Advisory Inc Halozyme Therapeutics, Inc. Transaction History